Literature DB >> 6151039

Vaccine prophylaxis of abattoir-associated Q fever.

B P Marmion, R A Ormsbee, M Kyrkou, J Wright, D Worswick, S Cameron, A Esterman, B Feery, W Collins.   

Abstract

Q fever is an important cause of morbidity in Australian meatworkers; recently there have been sharp outbreaks of Q fever in abattoirs in several states. In an attempt to control Q fever by vaccination, 924 nonimmune volunteers at two South Australian abattoirs were inoculated with one dose of a purified, formalin-inactivated, Coxiella burneti, Henzerling strain, phase 1 vaccine. Some 56% of workers in one abattoir, and 64% in the other, seroconverted after vaccination. In the 18 months after vaccination, no Q fever occurred in fully vaccinated subjects, whereas there were 34 cases in 1349 unvaccinated workers. Transient local reactions were noted in most vaccinated subjects; only a few had mild general reactions. No cases of vaccine-enhanced disease were observed. Vaccination of susceptible individuals with a purified C burneti phase 1 vaccine appears to be safe and effective in preventing Q fever in the abattoir.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151039     DOI: 10.1016/s0140-6736(84)91617-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.

Authors:  Chen Chen; Erin J van Schaik; Anthony E Gregory; Adam Vigil; Phillip L Felgner; Laura R Hendrix; Robert Faris; James E Samuel
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

2.  Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.

Authors:  A A Izzo; B P Marmion; T Hackstadt
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Q fever seroprevalence and associated risk factors among students from the Veterinary School of Zaragoza, Spain.

Authors:  M C Valencia; C O Rodriguez; O G Puñet; I de Blas Giral
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

4.  Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

Authors:  S J Tozer; S B Lambert; T P Sloots; M D Nissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-16       Impact factor: 3.267

5.  Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

6.  Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever.

Authors:  K E Russell-Lodrigue; G Q Zhang; D N McMurray; J E Samuel
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

7.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

Authors:  A Moos; T Hackstadt
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 8.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

9.  A systematic approach to evaluate humoral and cellular immune responses to Coxiella burnetii immunoreactive antigens.

Authors:  C Chen; T J Bouman; P A Beare; K Mertens; G Q Zhang; K E Russell-Lodrigue; J P Hogaboam; B Peters; P L Felgner; W C Brown; R A Heinzen; L R Hendrix; J E Samuel
Journal:  Clin Microbiol Infect       Date:  2009-03-11       Impact factor: 8.067

Review 10.  Control of rickettsial diseases.

Authors:  J Kazár; R Brezina
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.